Case Study

Serialization/Anti-Counterfeiting for Several Leading Pharmaceutical Manufacturers

Project Snapshot

Counterfeit drugs are a real danger to customers’ health. As falsified medicines become more sophisticated, the risk of them reaching patients increases. For that reason, government agencies around the world have implemented regulations with which pharmaceutical industry players have to comply.

Serialization and aggregation contribute to building end-to-end traceability in order to secure the global supply chain.

Sterling provided capital program management solutions for several pharmaceutical companies. We created teams including mechanical, controls, vision, validation, and packaging engineers. Our team supported projects worldwide to meet U.S., Asia, and EU serialization requirements. Lines were integrated with serialization hardware and software in Germany, Italy, Puerto Rico, and several locations in the United States.

  • A majority of the pharmaceutical global packaging lines had to be retrofitted simultaneously to meet the deadline.
  • Each pharmaceutical company had a large-scale project to meet these requirements, impacting the availability of limited resources with the required expertise.
  • Hardware and software were being developed throughout the integration phrase, due to new technology and tight deadline constraints.

Sterling's Solution

Established global teams of integration engineers to address a significant number of line upgrades in a very limited timeframe.

Modified packaging lines with vision cameras, printers, and line and site level software.
Coordinated with IT areas to implement data exchange between ERP systems with to line and site level software.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.